abrdn Life Sciences Investors (NYSE:HQL) Raises Dividend to $1.50 Per Share

abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Tuesday, November 10th. Shareholders of record on Friday, November 20th will be given a dividend of $1.50 per share on Monday, November 30th. This represents a $6.00 annualized dividend and a yield of 32.1%. The ex-dividend date of this dividend is Friday, November 20th. This is a 141.9% increase from abrdn Life Sciences Investors’s previous quarterly dividend of $0.62.

abrdn Life Sciences Investors Stock Performance

Shares of HQL remained flat at $18.67 during midday trading on Wednesday. The stock had a trading volume of 27,186 shares, compared to its average volume of 127,409. The firm has a fifty day moving average of $18.62 and a 200 day moving average of $18.28. abrdn Life Sciences Investors has a 12 month low of $15.66 and a 12 month high of $22.67.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors is a non-diversified, closed-end investment fund focused on companies in the life sciences and health care sectors. Rather than developing or selling products itself, the fund invests in businesses involved in areas such as biotechnology, pharmaceuticals, medical devices and related services. The fund seeks long-term capital appreciation through a portfolio that can include both publicly traded and privately held companies. Its investments may span U.S. and international markets.